1. Academic Validation
  2. Tumor-draining lymph nodes respond to immune checkpoint inhibition and orchestrate tumor immune remodeling

Tumor-draining lymph nodes respond to immune checkpoint inhibition and orchestrate tumor immune remodeling

  • Cancer Immunol Immunother. 2025 Oct 6;74(11):326. doi: 10.1007/s00262-025-04187-w.
Jinzhu Zhang 1 Jian Ma 1 Yaru Niu 1 Jialiang Liu 1 Zhexue Wang 1 Jinyuan Guo 2 Yongsheng Meng 3 Ruifang Sun 3 Zhen Zhang 4 Haiyi Liu 5 Juan Xu 6 Likun Zan 7 Xu Guan 8 Xishan Wang 9
Affiliations

Affiliations

  • 1 Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 17 Panjiayuan South Lane, Chaoyang, Beijing, 100021, China.
  • 2 Shanxi Medical University, Taiyuan, 030001, China.
  • 3 Department of Tumor Biobank, Shanxi Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, China.
  • 4 Department of Pathology, Shanxi Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, China.
  • 5 Department of Colorectal Surgery, Shanxi Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, China.
  • 6 College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150086, China.
  • 7 Department of Pathology, Shanxi Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030013, China. zanlikun@hotmail.com.
  • 8 Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 17 Panjiayuan South Lane, Chaoyang, Beijing, 100021, China. drguanxu@163.com.
  • 9 Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 17 Panjiayuan South Lane, Chaoyang, Beijing, 100021, China. wxshan_1208@126.com.
Abstract

Background: Immune checkpoint inhibitors have traditionally been understood to exert their effects primarily within the tumor microenvironment, particularly targeting CD8 + T cells. However, recent studies have highlighted a pivotal role of tumor-draining lymph nodes in mediating responses to immune checkpoint inhibitor therapy. This study aimed to elucidate the specific mechanisms by which tumor-draining lymph nodes respond to immune checkpoint inhibitor therapy and regulate the tumor microenvironment in human colorectal Cancer.

Methods: We performed single-cell RNA Sequencing and T cell receptor Sequencing on tumor-draining lymph nodes and tumor tissues from patients with colorectal Cancer. Through in-depth analysis of the single-cell data, we established the connection between TDLNs and tumor, and explored the impact of immune checkpoint inhibitor therapy on the immune microenvironment of tumor-draining lymph nodes. In addition, we conducted animal experiments to validate these findings.

Results: Our findings revealed that immune checkpoint inhibitor treatment induced the expansion of tumor-specific CD8 + effector memory T cells within tumor-draining lymph nodes, which may serve as a source for the progenitor-exhausted CD8 + T cells in the tumor microenvironment. Moreover, conventional dendritic cells type 1 and macrophages within tumor-draining lymph nodes facilitated this process. We also observed that immune checkpoint inhibitor therapy promoted the expansion of tumor-specific CD4 + follicular helper T cells in tumor-draining lymph nodes, which may explain the increase of CD4 + follicular helper T cells in the tumor microenvironment after immune checkpoint inhibitor therapy. These hypotheses were corroborated through experiments in mice.

Conclusions: Our findings delineate the critical regulatory function of tumor-draining lymph nodes in modulating the tumor microenvironment during Immune checkpoint inhibitor therapy.

Keywords

Colorectal cancer; Immune checkpoint inhibition; Tumor-draining lymph nodes.

Figures
Products